Pseudohypoparathyroidism secondary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]
Overview
Secondary prevention of measures in pseudohypoparathyroidism include regular serum and urinary calcium measurements monitoring.
Secondary Prevention
Secondary prevention measures in pseudohypoparathyroidism include:[1]
- Monitor therapy with regular serum and urinary calcium measurements
- Pseudohypoparathyroidism type 1b patients at an increased risk of developing hyperparathyroidism and hyperparathyroid bone disease should be maintained at sufficient doses of calcium and vitamin D to maintain serum calcium and PTH levels within the normal range.
References
- ↑ Neary NM, El-Maouche D, Hopkins R, Libutti SK, Moses AM, Weinstein LS (2012). “Development and treatment of tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1B”. J. Clin. Endocrinol. Metab. 97 (9): 3025–30. doi:10.1210/jc.2012-1655. PMC 3431579. PMID 22736772.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH